Westlake Chemical Partners LP
WLKPdata completeness 63%14 fiscal years on fileData notes: no data for concept 'totalDebt'; no data for concept 'stockholdersEquity'; no data for concept 'interestExpense'
i. The business — what you’d actually own
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $188.3M1 | $250.2M1 | $1.19B2 | $1.14B2 | $1.17B2 |
| Net income | $82.5M3 | $64.2M4 | $54.3M5 | $62.4M5 | $48.7M5 |
| Operating cash flow | $408.4M6 | $463.7M7 | $452M8 | $485M8 | $280.5M8 |
| Capital expenditure | $81.2M9 | $54.1M10 | $46.8M11 | $49M11 | $78.8M11 |
| Free cash flow (derived) | $327.3M6 | $409.6M7 | $405.2M8 | $436M8 | $201.7M8 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $17.1M12 | $64.8M13 | $58.6M14 | $58.3M15 | $44.3M15 |
| Diluted shares | — | — | — | — | — |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
iii. Is this a good business?
Moat signal · return on equity
— avg · 5y
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Management signal · capital allocation
— shares · 5y
Not enough history to read capital allocation.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
no diluted share count — cannot compute per-share value
DCF · Growth Exit 5Y
not applicable
no diluted share count — cannot compute per-share value
Earnings Power Value
not applicable
no diluted share count
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K · period ending 2021-12-31 · accession 0001604665-23-000009 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001604665-26-000010 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001604665-24-000010 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001604665-25-000011 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001604665-26-000010 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001604665-24-000010 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001604665-25-000011 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001604665-26-000010 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001604665-24-000010 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001604665-25-000011 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001604665-26-000010 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001604665-23-000009 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001604665-24-000010 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001604665-25-000011 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001604665-26-000010 (CashAndCashEquivalentsAtCarryingValue)